Adaptive Biotechnologies (NASDAQ:ADPT) Issues Earnings Results : vimarsana.com

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) released its earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.06), Briefing.com reports. The firm had revenue of $37.65 million during the quarter, compared to analyst estimates of $36.81 million. Adaptive Biotechnologies had a negative return […]

Related Keywords

Canada , Chad , R Mark Adams , Harlan Robins , Stacyl Taylor , Credit Suisse Group , Morgan Stanley , Adaptive Biotechnologies Company Profile , Adaptive Biotechnologies Corp , Vident Investment Advisory , Scotiabank , Securities Exchange Commission , Royal Bank , Adaptive Biotechnologies , Get Rating , Exchange Commission , Mark Adams , Investment Advisory , Suisse Group , Chad Robins , Chris Carlson , Adaptive Biotechnologies Daily , Nasdaq Adpt , Adpt , Medical , Earnings ,